Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: To examine changes in annual patterns of psychotropic medication use in Australia from 2007 to 2015. Methods: We used a 10% sample of individual-level nationwide dispensing claims for concessional beneficiaries dispensed psychotropic medications (stratified by class, subclass) to investigate annual trends and changes in the incidence and prevalence of use, median annual duration of exposure, proportion of people with single psychotropic dispensing and median defined daily doses per person dispensed each medicine per year. Results: Over the study period, there was a 26.1% decrease in the incidence and a 2.6% increase in the prevalence of all psychotropic medicine use. We observed a decrease in the annual incidence and prevalence of antidepressants (11.6% and 16.8%, respectively) but increases in the median annual duration of exposure (7.4%). Amitriptyline had the highest proportion of single dispensings of all antidepressants throughout the study period (26.5% in 2015) and defined daily doses per person dispensed each medicine per year increased by 20% for antidepressants overall. Benzodiazepine use decreased across all measures over the study period apart from long-term use (exposure for >240 days of the year), which in 2015 was 23.6% of those dispensed a benzodiazepine. We observed a relative increase in the incidence and prevalence of antipsychotic use (14.2% and 26.8%, respectively), and haloperidol had the highest proportion of single dispensings of any antipsychotic throughout the study period (47.5% in 2015). We observed a relative increase in the incidence and prevalence of attention-deficit hyperactivity disorder medication use of 114.0% and 101.8%, respectively, over the study period. Conclusion: Increasing doses and treatment durations of antidepressants warrants further investigation due to concerns about overuse. Single dispensings of amitriptyline and haloperidol may indicate off-label use and long-term use of benzodiazepines remains problematic. Despite increases in attention-deficit hyperactivity disorder medication use, prevalence of use is still much lower than the estimated prevalence of attention-deficit hyperactivity disorder in the adult population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824 · cited 1×
“(Fayyad et al., 2016).”
Agnew-Blais, J. C., Polanczyk, G. V., Danese, A., Wertz, J., Moffitt, T. E., & Arseneault, L. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0465 · Cited by 459
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians
Olfson, M., Kroenke, K., Wang, S., & Blanco, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08834 · Cited by 221 · cited 1×
“Increases in antidepressant and antipsychotic use appear to underlie these changes worldwide, although increases in the use of psychostimulants have also been reported (Ilyas and Moncrieff, 2012; Olfson et al., 2014; Renoux et al., 2016; Stephenson et al., 2013).”
BackgroundWong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217 · cited 6×
“The past two decades have seen worldwide increases in the pharmacological treatment of mental illness (Ilyas and Moncrieff, 2012; Medco Health Solutions, 2011; Stephenson et al., 2013).”
BackgroundResultInfluentialSelf-citationRenoux, C., Shin, J., Dell'Aniello, S., Fergusson, E., & Suissa, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13000 · Cited by 132 · cited 1×
“Increases in antidepressant and antipsychotic use appear to underlie these changes worldwide, although increases in the use of psychostimulants have also been reported (Ilyas and Moncrieff, 2012; Olfson et al., 2014; Renoux et al., 2016; Stephenson et al., 2013).”
BackgroundReviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study
Johnson, C. F., Macdonald, H. J., Atkinson, P., Buchanan, A. I., Downes, N., & Dougall, N. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x658304 · Cited by 105 · cited 1×
“However, recent international studies indicate trends toward longer durations of treatment (average of 4–5 years) and suggest that some of this may represent overuse (Johnson et al., 2012; Kjosavik et al., 2015).”
Background
Cited by
Ralph, S. J., & Espinet, A. J. (2018) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170042 · Cited by 160
“5% of single antipsychotic prescriptions being for haloperidol [83].”
BackgroundVan Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
The effects of social group interventions for depression: systematic review
Dingle, G. A., Sharman, L. S., Haslam, C., Donald, M., Turner, C., Partanen, R., Lynch, J., Draper, G., & van Driel, M. L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.125 · Cited by 54
A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy
Brett, J., Pearson, S., Daniels, B., Wylie, C. E., & Buckley, N. A. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14527 · Cited by 18
Scholten, W., Batelaan, N., & Van Balkom, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320933404 · Cited by 17
Metadata
- Authors
- Brett, J., Karanges, E. A., Daniels, B., Buckley, N. A., Schneider, C., Nassir, A., Zoega, H., McLachlan, A. J., & Pearson, S.-A.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2017-07-31
- Volume
- 51
- Issue
- 10
- Pages
- 990-999
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2741467355
- Cited by
- 70
- References
- 9
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure. https://app.cochat.ai/papers/10.1177/0004867417721018
- The paper
- Brett, J., Karanges, E. A., Daniels, B., Buckley, N. A., Schneider, C., Nassir, A., Zoega, H., McLachlan, A. J., & Pearson, S.-A. (2017). Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867417721018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.